WELCOME!

Our research focuses on developing synthetic nanoplatforms to direct immune cells as ‘living therapeutics’, through genetically programming cellular functions or molecularly targeting stimulatory/inhibitory pathways. Our team creates a unique working environment by fostering interdisciplinary and translational collaboration.